This effect has been noted in rat studies [4]
In many ways, Wegovy is simply a higher-dose version of Ozempic, as they both contain the same active ingredient
Vaeth M, Maus M, Klein-Hessling S, Freinkman E, Yang J, Eckstein M, et al
reduccin del riesgo absoluto, 0,79 % [IC del 95 %, 0,60 %-0,99 %]
Future Directions and Personalized Longevity Protocols Emerging peptide candidates such as mitochondrialderived MOTSc and the adiposemodulating spexin are gaining attention for their ability to boost fattyacid oxidation, promote brownfat thermogenesis, and suppress adipogenesis, offering a metabolic edge to conventional GHreleasing peptides
GLP 1 medications have been shown to lower inflammatory markers such as C-reactive protein